Skip to content
Screener

Kodiak Sciences Inc KOD Total Liabilities & Equity

Total Liabilities & Equity at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$41.73B+9.2%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
$228.19M-24.2%
KLR
Kalaris TherapeuticsKLRS
$109.81M+6.5%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$512.91M-0.5%
HRO
HarrowHROW
$419.54M+15.2%
PVL
Palvella TherapeuticsPVLA
$263.76M+232%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized;none issued
Common stock, $0.0001 par value – 490,000,000 shares authorized; 62,155,685 and 61,758,454 shares issued and outstanding, respectively66
Additional paid-in capital1,728,9581,716,082
Accumulated deficit(1,616,863)(1,558,705)
Total stockholders’ equity112,101157,383
Total liabilities and stockholders’ equity$306,006$351,533

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's total liabilities & equity?
Kodiak Sciences Inc (KOD) reported total liabilities & equity of $306.01M in Q1 2026.
How has Kodiak Sciences Inc's total liabilities & equity changed year-over-year?
Kodiak Sciences Inc's total liabilities & equity increased by 2.7% year-over-year, from $297.91M to $306.01M.
What is the long-term trend for Kodiak Sciences Inc's total liabilities & equity?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's total liabilities & equity has grown at a -19.9% compound annual growth rate (CAGR), from $1.07B to $351.53M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Kodiak Sciences Inc's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude